Home7CA • FRA
add
Camurus AB
Nakaraang pagsara
€53.10
Sakop ng araw
€48.86 - €50.35
Sakop ng taon
€45.66 - €62.60
Market cap
31.79B SEK
Average na Volume
16.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 558.34M | 43.17% |
Gastos sa pagpapatakbo | 280.17M | -0.10% |
Net na kita | 197.25M | 153.33% |
Net profit margin | 35.33 | 76.92% |
Kita sa bawat share | 3.29 | 149.24% |
EBITDA | 239.55M | 190.91% |
Aktuwal na % ng binabayarang buwis | 22.33% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.88B | 26.57% |
Kabuuang asset | 3.97B | 29.68% |
Kabuuang sagutin | 482.15M | 16.16% |
Kabuuang equity | 3.49B | — |
Natitirang share | 58.88M | — |
Presyo para makapag-book | 0.90 | — |
Return on assets | 15.46% | — |
Return on capital | 17.31% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 197.25M | 153.33% |
Cash mula sa mga operasyon | 77.64M | 113.70% |
Cash mula sa pag-invest | -34.14M | -1,992.16% |
Cash mula sa financing | -6.10M | -100.58% |
Net change in cash | 25.36M | -97.66% |
Malayang cash flow | -47.50M | -6,656.70% |
Tungkol
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Itinatag
1991
Website
Mga Empleyado
265
